Physicians International CT Utilization Registry 2

NCT ID: NCT02354196

Last Updated: 2017-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-31

Study Completion Date

2017-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the total plaque burden, plaque severity and composition of patients undergoing Cardiac CT who do not have any previous history of CVD. There are two cohorts:

1. A retrospective follow-up for MACE endpoints of patients who underwent a CCTA \>1 year ago as part of the Big PICTURE Trial, who meet the inclusion criteria of Big PICTURE 2.
2. A prospective observational registry of patients referred to undergo CCTA with a 1 and 2 year follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the original BIG PICTURE trial, the analysis of over 6000 subject's CCTA images found significant differences amongst patients of Arabic and south-east Asian descent, with regard to plaque burden, severity and composition. Due to the "all-comers" nature of that trial, the factors of diabetes, previous CVD, and other coronary risk factors were likely confounders in the results. In this trial, those subject selection is screened to eliminate those factors with the goal of working with a more homogenous population to perform the plaque analysis. This study is a multicenter, prospective, post marketing, observational registry study designed to describe frequency and patterns of various risk factors, indications and findings in patients who undergo CCTA.

BIG PICTURE 2 (abbreviated as "BP2") will collect data on patients from a wide variety of imaging sites (inpatient, outpatient, in-clinic CT machine). While the majority of the sites are within the US, the data collection will not be limited to US-only sites. A sub study of BP2 will perform a remote short follow-up questionnaire of subjects who were in the original Big PICTURE study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CCTA

Subjects who underwent a CCTA

CCTA

Intervention Type PROCEDURE

CT of heart to assess coronary disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CCTA

CT of heart to assess coronary disease

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cardiac CT Angiography

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* No prior CVD
* No hypertension
* No Diabetes
* Body mass index (BMI) \<35 kg/m2.

Exclusion Criteria

* \<18 years or older
* Prior CVD
* Hypertension
* Body mass index (BMI) \>=30 kg/m2.
* Diabetes Mellitus Type 1 or 2
* Current or previous history of smoking
* Pregnancy
* Planned intervention or bypass surgery
* Known complex congenital heart disease
* Planned invasive angiography for reasons other than CAD
* Non-cardiac illness with life expectancy \< 2 years
* Inability to provide written informed consent
* Concomitant participation in another clinical trial in which subject is subject to investigational drug or device
* Pregnant women
* Allergy to iodinated contrast agent
* Serum creatinine \>1.5 mg/dl or GFR \<30 ml/min
* Baseline irregular heart rhythm
* Heart rate ≥100 beats per minute
* Systolic blood pressure ≤90 mm Hg
* Contraindications to β blockers or nitroglycerin Strategies for Recruitment and Retention
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MDDX LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MDDX

San Francisco, California, United States

Site Status

FACTS

Hyderabad, , India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Big PICTURE 2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.